Almac confirm exhibition sponsorship of BOS Basel 2020
Bio2Business is pleased to welcome Almac as an exhibitor sponsor at BOS Basel 2020, which will take place on the 1st and 2nd of July, 2020, at the Congress Centre Basel in Switzerland. The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.
Dr Firelli Alonso, Senior Director, External Supply, BioTherapeutics & Vaccines Outsourcing, Pfizer, to present at BOS Basel 2020
Dr Firelli Alonso, Senior Director, External Supply, BioTherapeutics & Vaccines Outsourcing, Pfizer, will present in the Biologics CMC Outsourcing work-stream at BOS Basel 2020. Her confirmed presentation title is "Agile sourcing strategies for new therapeutic modalities".
Quality Assistance Confirm Exhibition Sponsorship at BOS Basel 2020
Bio2Business is delighted to welcome Quality Assistance as an Exhibition Sponsor at BOS Basel 2020. Meet their delegates at Booth Number 30. Quality Assistance is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
Almac Group, an established contract development and manufacturing organisation, provides the most unique range of integrated drug development services available to the pharmaceutical & biotech industry.
A privately owned organisation that has grown over 50 years, we now employ over 5,000 high skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with 17 global facilities across the UK, Ireland, USA and Asia.
Our quality, innovation and efficiency are testimony to over 600 companies worldwide who trust Almac for their Chemical, Pharmaceutical and Clinical Development needs.
Addressing the increasing pressure for Biopharma companies to bring their clinical candidates through their pipeline faster, more efficiently and at a lower cost, Almac provides an integrated CMC service, bridging the gap between drug substance and drug product development.
As an established provider of both drug substance (advanced intermediates and Active Pharmaceutical Ingredients - small molecules and peptides) and drug product development services, and by offering these within an integrated package, our client partners are assured of scientific continuity from a dedicated project team, resulting in significant savings in time and costs.
Integrated teams within Chemical and Pharmaceutical Development work closely to fully understand the physicochemical properties of the API to ensure the optimum chemical entity is available for the manufacture of clinical supplies.
Whether your requirements are for First in Human supplies or later phase development, manufacture or registration batches, Almac have access to a wide range of innovative technologies for potent and non-potent, solid oral dose products.
Having integrated chemical and pharmaceutical development operations, facilitates optimal communication and knowledge transfer on projects. Our clients leverage this combined offering, exploiting the Almac advantage of a single partner approach. Smoothing transition through the drug development process and commercialisation saves time, transfers and other uncertainties inherent in a multi-supplier process.
CARBOGEN AMCIS AG is a leading service provider, offering a portfolio of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries at all stages of drug development. Our integrated services for Drug Substances (DS) and Drug Products (DP) provide innovative solutions to support timely and safe drug development. CARBOGEN AMCIS is also active in the marketing/sales and manufacture of Vitamin D analogues, Vitamin D, Cholesterol and lanolin related products for key markets as pharmaceutical, cosmetic, food, feed as well as industry applications.
Our flexible approach enables customers to benefit from tailored packages of work which balance their needs in terms of speed, cost and quality. CARBOGEN AMCIS also adapts their communication and reporting to match customer specific requirements and documentation. CARBOGEN AMCIS has been part of Dishman Carbogen Amcis Limited since 2006.
Quality is central to the CARBOGEN AMCIS business. We provide services for the development and manufacture of highly potent drug substances (APIs) and drug products applying state-of-the-art containment technologies.
CARBOGEN AMCIS offers services starting from laboratory scale for process research and development purposes up to large scale manufacturing. To support the API development process through all stages, a variety of high containment analytical and purification capabilities complements the chemistry service portfolio. In addition to our process research and manufacturing services for the fast supply of highly potent APIs, CARBOGEN AMCIS offers conjugation services for Antibody Drug Conjugates (ADCs) as well as formulation and fill-and-finish services for drug products.
CARBOGEN AMCIS mission is to provide innovative solutions for drug development and supply to the pharmaceutical and biopharmaceutical industries that enable customers to bring new generation medicines to the market.
Quality Assistance - Your one-stop shop for analytical services // Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products. The company holds a unique position on the market with all its laboratories on one site, 180 highly qualified professionals and more than 35 yearsÃ¢â‚¬â„¢ expertise at the forefront of analytical sciences. We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences. For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs. Quality Assistance is an expert for the development of biologics (monoclonal antibodies, ADCs, proteins), New Chemical Entities (e.g. peptides, oligonucleotides), nanomedicine products, vaccines, Cell-Based and Gene Therapy Medicinal Products. Quality Assistance environment is GMP, GLC, GCLP/GCP compliant. Visit www.quality-assistance.com to learn more on our expertise and services as a leading analytical CRO and make sure you pass by at our stand #41.
Arcinova is a Contract Development and Manufacturing Organisation that helps pharmaceutical and biotechnology companies across the globe develop life changing medicines. We employ a multidisciplinary approach to drug development by combining the disciplines of chemistry, biology and bioinformatics. All our services are delivered from our 15,000m2 facility in the North of England.
We leverage our decades of experience as a key research and development centre for Sanofi and Covance to deliver high quality end-to-end solutions. Our mission is to deliver best-in-class technology services in the fields of contract research, development and small-scale manufacturing to overcome project challenges and increase efficiency.
BIO2BUSINESS LTD. London BioScience Innovation Centre, 2 Royal College Street, London. NW1 0NH. Tel: +44 (0)207 691 3568 BOS Media pack for 2020 events